A Prospective Study on the Application of Lateral Decubitus Position in Patients with Left Breast Cancer Undergoing Adjuvant Radiotherapy
Age range
18 Years – 70 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Radiotherapy Planning Dose-Volume Parameter -Volume of 5Gy heart dose
Timeframe: From study participation to the completion of the radiotherapy plan up to 2 years
Radiotherapy Planning Dose-Volume Parameter -Max dose of LAD
Timeframe: From study participation to the completion of the radiotherapy plan up to 2 years
Radiotherapy Planning Dose-Volume Parameter -mean heart dose
Timeframe: From study participation to the completion of the radiotherapy plan up to 2 years
Major Cardiovascular Events
Timeframe: From the initiation of radiotherapy to 2 years after its completion.
Subclinical Cardiovascular Events- Left ventricular ejection fraction (LVEF)
Timeframe: From the initiation of radiotherapy to 2 years after its completion.
Subclinical Cardiovascular Events- Left ventricular diastolic dysfunction
Timeframe: From the initiation of radiotherapy to 2 years after its completion.